At a glance
ClinicalIndex Comparison RecordN/ACompleted· 135 enrolled
Drug / intervention
Behavioral Interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Reducing Disparities in Medication Adherence of Patients With Systemic Lupus Erythematosus (SLE)
In Brief
A clinical study evaluating Behavioral Intervention for Systemic Lupus Erythematosus. Completed, enrolled 135 participants across 1 site.
Detailed Summary
This is a pilot study to assess the feasibility of using Surescripts refill data during the clinical encounter to improve medication adherence in patients with systemic lupus erythematosus
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSystemic Lupus Erythematosus
CountriesUnited States
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 2018
Enrollment StartOct 2019
Primary CompletionJun 2020
TodayJul 2026
First PostedNov 13, 2018
Enrollment StartOct 2, 2019
Primary CompletionJun 7, 2020
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 7.6 years ago
Interventions
Behavioral Interventionbehavioral
Lupus clinic providers will be prompted to assess adherence level using Surescripts refill information and address any adherence barriers that arise during the clinical encounter.